Home > Boards > US Listed > Biotechs > Aclaris Therapeutics, Inc. (ACRS)

lookslike good day for ACRS

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
ADVFN_bioking Member Profile
 
Followed By 21
Posts 630
Boards Moderated 0
Alias Born 05/15/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 5:39:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2021 4:12:43 PM
Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action GlobeNewswire Inc. - 8/27/2021 4:01:00 PM
Aclaris Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 8/26/2021 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 7:32:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 7:16:31 AM
Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2021 4:02:07 PM
Aclaris price target raised at Jefferies citing ‘significant stock moving event’ Seeking Alpha - 7/23/2021 3:37:32 PM
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021 GlobeNewswire Inc. - 7/8/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 6:04:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2021 4:02:30 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/10/2021 4:26:36 PM
Aclaris Therapeutics secures $125M capital via equity raise Seeking Alpha - 6/10/2021 12:29:04 AM
Aclaris Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 6/9/2021 7:55:00 PM
Aclaris to meet competition from Incyte in atopic dermatitis Seeking Alpha - 6/9/2021 1:46:03 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/8/2021 4:26:08 PM
Aclaris Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 6/8/2021 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2021 7:17:14 AM
Aclaris Therapeutics Announces Positive Preliminary Topline Data from Phase 2a Trial of ATI-1777 for Moderate to Severe Atopi... GlobeNewswire Inc. - 6/8/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2021 7:56:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2021 7:53:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2021 5:03:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/17/2021 6:06:35 PM
Aclaris Therapeutics to Participate in the Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/17/2021 7:00:00 AM
ADVFN_bioking   Wednesday, 10/09/19 09:25:18 AM
Re: None
Post # of 313 
lookslike good day for ACRS

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences